Hepatitis B virus reactivation mainly occurs in HBsAg- and anti-HBc-positive patients, but it also occurs in individuals with a prHBV infection.11 Among patients with a prHBV infection, HBVr mainly occurred in patients receiving rituximab-containing regimens with or without hematological diseases. Here, KRT88P is linked to hematologic disorder.